NCT02468167Unknown不适用
Comparison of Endoscopic Cyanoacrylate Injection Versus Balloon-occluded Retrograde Transvenous Obliteration in the Management of Acute Gastric Variceal Bleeding
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 入组人数
- 70
- 试验地点
- 1
- 主要终点
- The number of participants with failure to control acute bleeding or failure to prevent clinically significant variceal rebleeding within 1 year after enrollment
研究概览
简要总结
The purpose of this study is to study the efficacy of endoscopic cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration in the management of acute gastric bleeding.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Active bleeding from gastric varices (GOV2 or IGV1)
- •Presence of gastrorenal shunt
排除标准
- •Previous pharmacologic therapy combined with endoscopic treatment to prevent rebleeding
- •Previous use of TIPS or surgical shunt
- •Non-cirrhotic portal hypertension
- •Contraindications to cyanoacrylate injection or BRTO
- •Portal cavernoma
- •Hepatorenal syndrome
- •Proven malignancy including hepatocellular carcinoma
- •End-stage renal disease under renal replacement therapy;
- •Cardiorespiratory failure
- •Pregnancy or patients not giving informed consent for endoscopic procedures
研究组 & 干预措施
NBCA
Active Comparator
Endoscopic cyanoacrylate injection
干预措施: Endoscopic cyanoacrylate injection (Procedure)
BRTO
Active Comparator
Balloon-occluded retrograde transvenous obliteration
干预措施: Balloon-occluded retrograde transvenous obliteration (Procedure)
BRTO
Active Comparator
Balloon-occluded retrograde transvenous obliteration
干预措施: Lauromacrogol (Drug)
NBCA
Active Comparator
Endoscopic cyanoacrylate injection
干预措施: N-butyl-2-cyanoacrylate (Drug)
结局指标
主要结局
The number of participants with failure to control acute bleeding or failure to prevent clinically significant variceal rebleeding within 1 year after enrollment
时间窗: 1 year
次要结局
- Mortality rate(3 years)
- Cost of treatment(3 years)
- Eradication rate of gastric varices(3 years)
- Number of participants with increase or decrease in the size of gastric varices(3 years)
- Number of participants with appearance or worsening of portal hypertensive gastropathy(3 years)
- Number of participants with appearance or worsening of ascites(3 years)
- Average in-hospital stay(3 years)
- Number of participants with appearance or worsening of new oesophageal varices(3 years)
- Number of participants with complication(3 years)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Secondary Prophylaxis of Gastric Variceal BleedGastric VaricesNCT02468206West China Hospital64
已完成
不适用
Injection of Cyanoacrylate+Lipiodol vs Cyanoacrylate+Lauromacrogol in Gastric VaricesGastric VaricesPortal HypertensionNCT01923064Shanghai Zhongshan Hospital96
已完成
4 期
Comparison of Endoscopic Injection of Conventional and Double Doses Cyanoacrylate for Gastric Variceal HemorrhageGastric Variceal BleedingNCT00735358Taipei Veterans General Hospital, Taiwan105
已完成
3 期
N-Butyl-2-Cyanoacrylate Injection Versus Band Ligation for Gastric Variceal HemorrhageGastric Variceal HemorrhageNCT00292331Taipei Veterans General Hospital, Taiwan120
Unknown
不适用
SAFETY AND EFFICACY OF ENDOSCOPIC CONVENTIONAL CYANOACRYLATE GLUE VS EUS-GUIDED COIL PLUS CYANOACRYLATE TECHNIQUE IN THE TREATMENT OF GASTRIC VARICES: A RANDOMIZED CONTROLLED TRIALDependence GlueNCT05038319Asian Institute of Gastroenterology, India34